The Discounted Cash Flow (DCF) valuation of Addex Therapeutics Ltd (ADXN.SW) is (1.31) CHF. With the latest stock price at 0.06 CHF, the upside of Addex Therapeutics Ltd based on DCF is -2281.2%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 3.8% - 5.3% | 4.6% |
| Long-term Growth Rate | 3.0% - 3.3% | 3.1% |
| Fair Price | (3.33) - (0.81) | (1.31) |
| Upside | -5648.7% - -1458.1% | -2281.2% |